These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117 [TBL] [Abstract][Full Text] [Related]
3. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification. Leung SM; Pitts RL Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311 [TBL] [Abstract][Full Text] [Related]
4. [Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry]. Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; He DC; Zhao XJ; Yang BX Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3172-5. PubMed ID: 16405834 [TBL] [Abstract][Full Text] [Related]
5. A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification. Wong MY; Yu KO; Poon TC; Ang IL; Law MK; Chan KY; Ng EW; Ngai SM; Sung JJ; Chan HL Electrophoresis; 2010 May; 31(10):1721-30. PubMed ID: 20414880 [TBL] [Abstract][Full Text] [Related]
6. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
7. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963 [TBL] [Abstract][Full Text] [Related]
8. [Proteomics and breast cancer]. Mathelin C; Tomasetto C; Cromer A; Rio MC Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic protein discovery using proteolytic peptide targeting and identification. Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157 [TBL] [Abstract][Full Text] [Related]
10. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology]. Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841 [TBL] [Abstract][Full Text] [Related]
11. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer]. Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540 [TBL] [Abstract][Full Text] [Related]
13. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Hardouin J Mass Spectrom Rev; 2007; 26(5):672-82. PubMed ID: 17492750 [TBL] [Abstract][Full Text] [Related]
14. [Identification of colorectal cancer using proteomic patterns in serum]. Zhao G; Gao CF; Song GY; Li DH; Wang XL Ai Zheng; 2004 Jun; 23(6):614-8. PubMed ID: 15191657 [TBL] [Abstract][Full Text] [Related]
15. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
16. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers]. Solassol J; Marin P; Maudelonde T; Mangé A Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265 [TBL] [Abstract][Full Text] [Related]
17. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459 [TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics and mass spectrometry profiling for cancer detection. Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703 [TBL] [Abstract][Full Text] [Related]